Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice.

Fatty acid-binding proteins (FABPs) facilitate the diffusion of fatty acids within cellular cytoplasm. Compared with C57Bl/6J mice maintained on a high-fat diet, adipose-FABP (A-FABP) null mice exhibit increased fat mass, decreased lipolysis, increased muscle glucose oxidation, and attenuated insulin resistance, whereas overexpression of epithelial-FABP (E-FABP) in adipose tissue results in decreased fat mass, increased lipolysis, and potentiated insulin resistance. To identify the mechanisms that underlie these processes, real-time PCR analyses indicate that the expression of hormone-sensitive lipase is reduced, while perilipin A is increased in A-FABP/aP2 null mice relative to E-FABP overexpressing mice. In contrast, de novo lipogenesis and expression of genes encoding lipoprotein lipase, CD36, long-chain acyl-CoA synthetase 5, and diacylglycerol acyltransferase are increased in A-FABP/aP2 null mice relative to E-FABP transgenic animals. Consistent with an increase in de novo lipogenesis, there was an increase in adipose C16:0 and C16:1 acyl-CoA pools. There were no changes in serum free fatty acids between genotypes. Serum levels of resistin were decreased in the E-FABP transgenic mice, whereas serum and tissue adiponectin were increased in A-FABP/aP2 null mice and decreased in E-FABP transgenic animals; leptin expression was unaffected. These results suggest that the balance between lipolysis and lipogenesis in adipocytes is remodeled in the FABP null and transgenic mice and is accompanied by the reprogramming of adipokine expression in fat cells and overall changes in plasma adipokines.

[1]  D. Bernlohr,et al.  Interaction of rat hormone-sensitive lipase with adipocyte lipid-binding protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. E. Hammond,et al.  Mitochondrial Glycerol-3-phosphate Acyltransferase-1 Is Essential in Liver for the Metabolism of Excess Acyl-CoAs* , 2005, Journal of Biological Chemistry.

[3]  I. G. Fantus,et al.  Mechanisms of the Free Fatty Acid-induced Increase in Hepatic Glucose Production Ffa and Gluconeogenesis Hepatic Insulin Signaling , 2022 .

[4]  J. Lovejoy The influence of dietary fat on insulin resistance , 2002, Current diabetes reports.

[5]  J. Veerkamp,et al.  New insights into the structure and function of fatty acid-binding proteins , 2002, Cellular and Molecular Life Sciences CMLS.

[6]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.

[7]  G. Paolisso,et al.  Role of non‐esterified fatty acids in the pathogenesis of Type 2 diabetes mellitus , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[8]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[9]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[10]  R. Parker,et al.  Role of the fatty acid binding protein mal1 in obesity and insulin resistance. , 2003, Diabetes.

[11]  J. Suttles,et al.  The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. , 2005, The Journal of biological chemistry.

[12]  M. Lane,et al.  Induction of lipogenesis during differentiation in a "preadipocyte" cell line. , 1976, The Journal of biological chemistry.

[13]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[14]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[15]  D. Bernlohr,et al.  Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.M200227-JLR200 , 2002, Journal of Lipid Research.

[16]  D. Bernlohr,et al.  Physiological properties and functions of intracellular fatty acid-binding proteins. , 1998, Biochimica et biophysica acta.

[17]  P. J. Randle,et al.  Metabolic fuel selection: general integration at the whole-body level , 1995, Proceedings of the Nutrition Society.

[18]  S. Enerbäck,et al.  Insulin resistance and type 2 diabetes--an adipocentric view. , 2003, Current molecular medicine.

[19]  P. Scherer,et al.  Adiponectin: Systemic contributor to insulin sensitivity , 2003, Current diabetes reports.

[20]  D. Bernlohr,et al.  Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. , 1999, Journal of lipid research.

[21]  R. Rizza,et al.  Fat-induced liver insulin resistance , 2003, Current diabetes reports.

[22]  S. O’Rahilly,et al.  Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. , 2002, Endocrinology.

[23]  M. Prentki,et al.  Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. , 2005, American journal of physiology. Endocrinology and metabolism.

[24]  C. Kahn,et al.  Role of Insulin Action and Cell Size on Protein Expression Patterns in Adipocytes* , 2004, Journal of Biological Chemistry.

[25]  R. Giacco,et al.  Dietary fat, insulin sensitivity and the metabolic syndrome. , 2004, Clinical nutrition.

[26]  J. Suttles,et al.  The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.

[27]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[28]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[29]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[30]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[31]  J. Girard,et al.  Control of gene expression by fatty acids. , 2004, The Journal of nutrition.

[32]  R. Leibel,et al.  Effects of obesity on the relationship of leptin mRNA expression and adipocyte size in anatomically distinct fat depots in mice. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  J. Storch,et al.  Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. , 2000, Diabetes.

[34]  P. J. Randle,et al.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.

[35]  S Kumar,et al.  Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[36]  C. Picó,et al.  Resistin expression in different adipose tissue depots during rat development , 2003, Molecular and Cellular Biochemistry.

[37]  R. Bonow,et al.  The diabetes epidemic: a national and global crisis. , 2004, The American journal of medicine.

[38]  M. Rodbell METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. , 1964, The Journal of biological chemistry.

[39]  Manabu T. Nakamura,et al.  Mechanisms of regulation of gene expression by fatty acids , 2004, Lipids.

[40]  D. Bernlohr,et al.  Physical Association between the Adipocyte Fatty Acid-binding Protein and Hormone-sensitive Lipase , 2004, Journal of Biological Chemistry.

[41]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[42]  J. Proietto,et al.  Effects of free fatty acids on insulin secretion in obesity , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[43]  J. Olefsky Mechanisms of decreased insulin responsiveness of large adipocytes. , 1977, Endocrinology.

[44]  C. Tomkiewicz,et al.  Expression of macrophage‐selective markers in human and rodent adipocytes , 2005, FEBS letters.

[45]  B. Howard,et al.  Dyslipidemia of the metabolic syndrome , 2002, Current cardiology reports.

[46]  S. O’Rahilly,et al.  Induction of Adipocyte Complement-related Protein of 30 Kilodaltons by Ppar␥ Agonists: a Potential Mechanism of Insulin Sensitization , 2022 .

[47]  Jeffrey B. Boord,et al.  Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[48]  Jeffrey B. Boord,et al.  Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[49]  S. Bonner-Weir,et al.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2. , 2000, Endocrinology.

[50]  G. Cooney,et al.  The role of intramuscular lipid in insulin resistance. , 2003, Acta physiologica Scandinavica.

[51]  G. Shulman,et al.  Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance. , 2005, Diabetes.

[52]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[53]  J. Flier,et al.  Adipose Tissue as an Endocrine Organ , 2014 .

[54]  R. Ahima,et al.  Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. , 2004, Diabetes.

[55]  E. Seidman,et al.  Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[56]  R. Parker,et al.  Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. , 1999, Diabetes.

[57]  D. Bernlohr,et al.  Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. , 2005, American journal of physiology. Endocrinology and metabolism.

[58]  J. Tuomilehto,et al.  Metabolic syndrome, diabetes, and coronary heart disease , 2005 .

[59]  I. Gabriely,et al.  Differential Gene Expression Between Visceral and Subcutaneous Fat Depots , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[60]  P. Scherer,et al.  ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.

[61]  S. Rapoport,et al.  Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. , 1994, Analytical biochemistry.

[62]  John A Wagner,et al.  Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity* , 2004, Journal of Biological Chemistry.

[63]  C. Park,et al.  Mechanism of long chain fatty acid permeation in the isolated adipocyte. , 1981, The Journal of biological chemistry.